Clarivate Plc Stock Price, News & Analysis

Clarivate has successfully completed its acquisition of ProQuest for $5.3 billion, enhancing its position as a global leader in information and analytics. This acquisition, announced on May 17, 2021, adds ProQuest's software, content, and analytics capabilities to Clarivate's portfolio. The combined entity now boasts over 11,000 employees serving 45,000 customers worldwide. The integration aims to unlock synergies and offer enriched services to research-focused organizations, while maintaining investment in existing product lines. Key leadership changes include Jonathan Collins as the new CFO.

Clarivate Plc (NYSE: CLVT) announced that its Executive Chairman Jerre Stead and CFO Richard Hanks will present at two upcoming virtual investor conferences. The presentations will take place at the BofA Securities Leveraged Finance Conference on November 30, 2021, at 8:15 am ET, and the Barclays Global Technology, Media, and Telecommunications Conference on December 7, 2021, at 3:35 pm ET. Webcasts for both events will be available for live access and replay. For more details, please visit Clarivate's website.

Clarivate Plc (NYSE:CLVT) has released its 2021 Highly Cited Researchers list, identifying 6,602 researchers globally, with 39.7% based in the United States, a decrease from previous years. Mainland China has seen significant growth, now boasting 935 researchers, nearly doubling its presence in four years. Key institutions include Harvard University with 214 researchers. This reflects a trend of globalization in research, with declines observed in the U.S. and U.K.

Clarivate Plc (NYSE: CLVT) announced that Executive Chairman Jerre Stead and CFO Richard Hanks will present at virtual investor conferences in November 2021. The first event is the RBC Capital Markets Global Technology Conference on November 17, 2021, at 9:35 AM ET, with a live webcast available for replay. The second event is the BofA Securities 2021 Leveraged Finance Conference on November 30, 2021, at 8:15 AM ET, also with a live webcast accessible for replay. For more details, visit clarivate.com.

Clarivate Plc (NYSE:CLVT) has been recognized by Forrester in their latest B2B2C Journey Mapping reports. These reports highlight the importance of transparency and trust in enhancing customer experiences. Clarivate's Customer Experience (CX) Services emphasizes the need for effective customer journey mapping, beginning with understanding customer feedback. The company also stresses the significance of recognizing partners' roles in customer experiences. This recognition underscores Clarivate's commitment to improving customer insights and driving business success.

Clarivate has partnered with the Biomedical Advanced Research and Development Authority (BARDA) to expedite the development of drug therapeutics that can serve as medical countermeasures (MCMs) for chlorine and sulfur mustard injuries. This collaboration will utilize machine learning and artificial intelligence to identify and repurpose existing FDA-approved drugs. Funding from BARDA will facilitate target identification and analyses, aiming to provide quicker responses to chemical exposure incidents. This initiative is part of BARDA's ReDIRECT program to enhance public health preparedness.

On November 2, 2021, Clarivate Plc (NYSE: CLVT) announced a Virtual Investor Day scheduled for November 9, 2021. The event will provide updates on the company's business, with presentations from 10:00 AM to 1:00 PM Eastern Time. Participants can join via webcast through the Clarivate Investor Relations website. A replay will also be available afterwards. Clarivate aims to accelerate innovation through trusted information and insights, helping clients navigate complex challenges in science and intellectual property.

Clarivate Plc (NYSE:CLVT) has been selected by Hewlett Packard Enterprise (HPE) as its IP lifecycle management partner. This collaboration enables HPE to utilize Clarivate's IPfolio and Innography to streamline administrative processes and enhance innovation strategies. HPE will benefit from improved management of its extensive patent and trademark portfolio, enabling faster decision-making and better resource allocation. The integration of CompuMark’s trademark research into IPfolio allows for comprehensive trademark management, reinforcing HPE's objectives in innovation and business transformation.